Previous release had an incorrect area code on the contact phone
number (888 should have been 833). This has been corrected.
Juva Life Inc.
(CSE:
JUVA) (OTC:
JUVAF) (“Juva
Life,”
“Juva” or the
“Company”), a premier California based
multi-faceted life sciences company focused on the
commercialization of Cannabis products and formulations, is pleased
to announce the commencement of trading its common shares on the
Canadian Securities Exchange (“CSE”) under the ticker symbol
“JUVA.” Additional information is being updated on the Company
website at www.juvalife.com.
Juva Life Inc. USA, a California corporation and
wholly owned subsidiary of Juva Life Inc. (as of May 30, 2019) was
originally incorporated in 2018 and represents the culmination of
decades of concentrated effort in the cannabis sector. Juva
Stockton Inc., a wholly owned subsidiary of Juva Life Inc., holds a
Conditional Use Permit (“CUP”) from the city of Stockton,
California which, subject to certain conditions, permits the
Company to cultivate, manufacture, distribute and deliver cannabis
for the medical and recreational markets within the State. Juva
Stockton successfully launched its delivery service from this
location on the 16th of October 2020. Additionally, in January
2020, after a 2.5-year process, Precision Apothecary Inc, a wholly
owned subsidiary of Juva Life Inc., now holds a CUP allowing for a
Microbusiness operation in the City of Hayward, California. This
permit allows Juva to cultivate, manufacture, distribute and
operate a retail cannabis storefront and delivery business in that
municipality. Concurrently, the Company’s Redwood City delivery
location has been fully operational since February 2020 and has
experienced double-digit growth month over month since commencement
of operations.
Under the guidance of founder & CEO Doug
Chloupek, the Juva Life team brings together over 20 years of
extensive leadership experience in the cannabis sector. Their
knowledge and experience provide operational oversight and
understanding of the California cannabis market. The Company is
comprised of six divisions: cultivation, research, manufacturing,
distribution, retail, and delivery. Each division services specific
vertical markets within a fully integrated framework under the
guiding premise of commercially engaging the many ways cannabis can
fundamentally improve individual quality of life.
Mr. Doug Chloupek, CEO and Founder of Juva Life
Inc. states, “Our journey has been truly extraordinary to-date. We
are extremely grateful to have completed an extraordinarily
successful Regulation-A+ financing along with several traditional
financings. These financings have provided us the cash on hand to
execute our strategy while concurrently moving ahead with today’s
public listing and access to an even broader investment community.
We are thrilled to start our journey as a publicly listed issuer
today. We sincerely value the participation of the investment
community and have made it a key pillar and measure of our success
to strategically build shareholder value as we forge ahead in this
exciting and evolving industry sector.”
As part of the Company’s disclosure obligations
as a public issuer, ongoing financial and material filings can be
found on the System for Electronic Document Analysis and Retrieval
(SEDAR) at www.sedar.com.
About Juva Life
Inc. (CSE: JUVA) (OTC: JUVAF)Juva
Life is working to bring the cannabis market face to face with
the sector’s next generation investment grade business model. From
in-house research, cultivation, manufacturing, retail, and delivery
services, Juva employs state of the art tools in discovery,
development, and data science to identify new molecular entities
for major unmet medical needs. Our initial focus is on cannabis,
where we are deploying our platform to target consumer and pharma
applications. Find out more
at: https://juvalife.com/.
For further information, please contact:Juva
Life Investor RelationsTel: +1 833-333-5882 (JUVA)Email:
inquiries@juvalife.com
Forward Looking Statement This
news release contains statements and information that, to the
extent that they are not historical fact, may constitute
“forward-looking information” within the meaning of applicable
securities legislation. Forward-looking information may include
financial and other projections, as well as statements regarding
future plans, objectives, or economic performance, or the
assumption underlying any of the foregoing. In some cases,
forward-looking statements can be identified by terms such as
“may”, “would”, “could”, “will”, “likely”, “except”, “anticipate”,
“believe”, “intend”, “plan”, “forecast”, “project”, “estimate”,
“outlook”, or the negative thereof or other similar expressions
concerning matters that are not historical facts. Examples of such
statements include, but are not limited to, statements with respect
to the objectives and business plans of the Company; ability to
realize benefits from its recent corporate appointments; ability to
retain its key personnel; the intention to grow the Company’s
business and operations; the competitive conditions of the
industries in which the Company operates; and laws and any
amendments thereto applicable to the Company.
Forward-looking information is based on the
assumptions, estimates, analysis and opinions of management made in
light of its experience and its perception of trends, current
conditions and expected developments, as well as other factors that
management believes to be relevant and reasonable in the
circumstances at the date that such statements are made, but which
may prove to be incorrect. The material factors and assumptions
used to develop the forward-looking information contained in this
news release include, but are not limited to, key personnel and
qualified employees continuing their involvement with the Company;
and the Company’s ability to secure financing on reasonable
terms.
Forward-looking information involves known and
unknown risks, uncertainties and other factors that may cause the
actual results, performance or achievements of the Company to
differ materially from any future results, performance or
achievements expressed or implied by the forward-looking
information, including, without limitation, risks relating to the
future business plans of the Company; risks that the Company will
not be able to retain its key personnel; risks that the Company
will not be able to secure financing on reasonable terms or at all,
as well as all of the other risks as described in the Company’s
management discussion and analysis for year ended December 31, 2019
under the heading “Risks and Uncertainties”. Accordingly, readers
should not place undue reliance on any such forward-looking
information. Further, any forward-looking information speaks only
as of the date on which such statement is made. New factors emerge
from time to time, and it is not possible for the Company’s
management to predict all of such factors and to assess in advance
the impact of each such factor on the Company’s business or the
extent to which any factor, or combination of factors, may cause
actual results to differ materially from those contained in any
forward-looking information. The Company does not undertake any
obligation to update any forward-looking information to reflect
information or events after the date on which it is made or to
reflect the occurrence of unanticipated events, except as required
by law, including securities laws.
The CSE does not accept responsibility
for the adequacy or accuracy of this release.
Juva Life (CSE:JUVA)
Historical Stock Chart
From Nov 2024 to Dec 2024
Juva Life (CSE:JUVA)
Historical Stock Chart
From Dec 2023 to Dec 2024
